期刊文献+

原发性眼睑痉挛100例临床分析 被引量:10

Clinical analysis of primary blepharospasm: A report of 100 cases
下载PDF
导出
摘要 目的分析原发性眼睑痉挛患者临床特点及治疗情况,提高临床医师对该病的临床诊治率。方法回顾性分析我院收治的100例原发性眼睑痉挛患者的一般资料、早期表现、诊断及治疗情况。结果 100例原发性眼睑痉挛患者的发病年龄为(56.4±2.7)岁,确诊时病程为2~120个月,平均30个月。100例患者中眼干涩是最常见的早期非痉挛症状(54例),其后依次是眼睑睁开费力(39例)、眨眼次数增多(32例)、畏光(32例)。100例患者中仅10例初次就诊时被正确诊断,有90例早期诊断为其他疾病,包括干眼症、结膜/角膜炎、重症肌无力、神经症等。结论原发性眼睑痉挛的早期临床表现多样,早期识别率低,大多数病例未得到及时正确的治疗,眼科医师应提高对该病的认识。 Ohjeetive To analyze the clinical characteristics and treatment of primary blepharospasm, and improve the rate of diagnosis and treatment. Methods A retrospective analysis of clinical date of 100 blepharospasm patients in our hospital was performed, including general information, early manifestations, diagnosis and treat- ments. Results The age at onset of the 100 patients was (56.4 _+ 2.7) years,the dura- tion was from 2 months to 120 months,averaged 30 months. Dry eye was the most com- mon of early non-spasm symptoms (54 cases), followed by eyelid open laborious (39 cases) ,increased blink frequency ( 32 cases), photophobia ( 32 cases). In the 100 cases, while only l0 cases were correctly diagnosed at the initial visit,90 cases were early diag- nosed for other diseases, such as dry eye, conjunctival / keratitis, myasthenia gravis, mental disorders, etc. Conclusion Early clinical manifestations of blepharospasm di- verse, early recognition is low ,the majority of cases have not gotten timely and correct treatment, and the clinical physician should pay attention to this disease.
出处 《眼科新进展》 CAS 北大核心 2015年第2期143-145,共3页 Recent Advances in Ophthalmology
基金 辽宁省自然科学基金资助(编号:201102052)~~
关键词 眼睑痉挛 干眼症 重症肌无力 抑郁症 blepharospasm dry eye myasthenia gravis depression
  • 相关文献

参考文献14

  • 1Hallett M, Evinger C, Jankovic J, Stacy M. Update on blepharo- spasm: report from the BEBRF international workshop [J].Neu- rology,2008,71 ( 16 ) : 1275-1282.
  • 2Poston KL, Eidelberg D. Functional brain networks and abnor- mal connectivity in the movement disorders[J].Neuro Image, 2012,52 (4) : 2251-2270.
  • 3Biuk D, Karin AA, Matid S, Bara6 J, Benasic T, Stiglmayer N. Quality of life in patients with blep- harospasm[J].CoU Antro- pol,2013,37( 1 ) :29-33.
  • 4Hwang WJ. Demographic and clinical features of patients with blepharospasm in southern taiwan: a university hospital-based study [ J]. Acta Neurol.2012.21 ( 3 ):108-114.
  • 5肌张力障碍诊断与治疗指南[J].中华神经科杂志,2008,41(8):570-573. 被引量:70
  • 6Elston JS, Marsden CD, Grandas F, Quinn NP. The significance of ophthalmological symptoms in idiopathic blepharospasm[J]. Eye(Lond) ,1988,2(4) :435-439.
  • 7Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm: a review of 264 patients [J]. J Neurol Neurosurg Psychiatry, 1988 (6) :767-772.
  • 8Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, et al. The infu- ence of benign essential bleph- arospasm on dry eye disease and ocular inflammation[J]. Am J Ophthalmol, 2014,157 ( 3 ) : 591 - 597.
  • 9Peekham EL, Lopez G, Shamim EA, Richardson SP, Sanku S, Malkani R, et al. Clinical features of patients with blepharo- spasm: a report of 240 cases [J]. Eur J Neurol,2011,18 ( 3 ) : 382 - 386.
  • 10Defazio G, Abbruzzese G, Aniello MS, Di Fede R, Esposito M, Fabbrini G, et al. Eye symptoms in relatives of patients with pri- mary adult-onset dystonia[J]. Mov Disord, 2012,27 ( 2 ) : 305- 307.

二级参考文献17

  • 1Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary ( idiopathic ) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. EurJ Neurol, 2006,13: 433-444.
  • 2Klein C, Friedman J, Bressman S, et al. Genetic testing for earlyonset torsion dystonia ( DYT1 ) : introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test, 1999, 3:323-328 .
  • 3Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology, 2000, 54: 1746- 1752.
  • 4Robinson R, McCarthy GT, Bandmann O, et al. GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness. J Neurol Neurosurg Psychiatry, 1999, 66 : 86-89.
  • 5Valente EM, Edwards MJ, Mir P, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology, 2005, 64: 737-739.
  • 6Meunier S, Lehericy S, Gamero L, et al. Dystonia: lessons from brain mapping . Neuroscientist, 2003, 9: 76-81.
  • 7Jankovic J. Treatment of dystonia. Lancet Neurol, 2006, 5 : 864- 872.
  • 8Berardelli A, Abbruzzese G, Bertolasi L, et al. Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci, 1997, 18: 261-269.
  • 9Tarsy D, Simon DK. Dystonia. N Engl J Med, 2006,355:818- 829.
  • 10Geyer H, Bressman SB. The diagnosis of dystonia. Lancet Neurol, 2006, 5: 780-790.

共引文献69

同被引文献88

引证文献10

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部